Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 11;4(1):198.
doi: 10.1038/s43856-024-00594-9.

Antimicrobial drug pricing

Affiliations

Antimicrobial drug pricing

Avaneesh Kumar Pandey et al. Commun Med (Lond). .

Abstract

Despite the constant development of antimicrobial resistance (AMR), few new antimicrobials are currently becoming available clinically. Alternative approaches, such as different mechanisms to fund their use, are being explored to encourage development of new antimicrobials.

PubMed Disclaimer

Conflict of interest statement

The authors declare the following competing interests: BW sits on the board of directors for the York Health Economic Consortium, a health economics consulting company wholly owned by the University of York. This role is unpaid. C.L., T.R., H.T. and Z.R. are employees of Pfizer. T.A. is an elected member of BSAC council and leads a consultancy across the AMR sector for organisations which have recently included The Microbiology Society, The UK Sepsis Trust, The Infection Management Coalition, Menarini Pharmaceuticals, Binary Pharmaceuticals, ESSITY and Pharmafilter. T.A. is a committee member for the GARDP/BSAC Antimicrobial Chemotherapy Conference 2025. T.A. is a GMC registered physician and prescriber. M.A. is the Deputy Chief Executive Officer of the British Society for Antimicrobial Chemotherapy (BSAC). As part of this role, T.A. helps to provide the Secretariat for the UK’s All-Party Parliamentary Group on Antimicrobial Resistance (AMR). T.A. also sits on the Steering Committee of the Trinity Challenge and is a Trustee of the Charades Theatre Company I.B. reports investigator-initiated research funding from Shionogi B.V. for research on Gram-negative infections; honoraria from Shionogi B.V. and Menarini UK; participating in an advisory board for GSK on the UK subscription model for antimicrobials. The other authors declare no competing interests.

Figures

None
(Left to right) Avaneesh Kumar Pandey, Nusrat Shafiq, Ashish Kumar Kakkar, Samir Malhotra Seema Prajapati
None
the Author
None
Christopher Little (top left), Tom Rhodes (top right), Harriet Tuson (bottom left) and Zeshan Riaz (bottom right) the Authors
None
Tom Ashfield (top) and Michael Corley (bottom) the Author
None
the Author

References

    1. DRUG-RESISTANT INFECTIONS A Threat to Our Economic Future. www.worldbank.org Published online 2017. (2024).
    1. WHO Model List of Essential Medicines − 23rd list, 2023. https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2023.02 (2024).
    1. Andrade, C., Shah, N. & Chandra, S. The new patent regime: implications for patients in India. Indian J. Psychiatry49, 56 (2007). - DOI - PMC - PubMed
    1. Compulsory Licensing in India and changes brought to it by the TRIPS Agreement - European Commission. https://intellectual-property-helpdesk.ec.europa.eu/news-events/news/com... (2024).
    1. Straka, R. J., Keohane, D. J. & Liu, L. Z. Potential clinical and economic impact of switching branded medications to generics. Am. J. Ther.24, e278 (2017). - DOI - PMC - PubMed

LinkOut - more resources